Selected research
Industry Growth & Trends
Global Cell therapy platform Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Cell therapy platform market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Cell therapy platform is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Cell therapy platform is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Cell therapy platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Cell therapy platform market include Novartis, Gilead Sciences, Regeneron Pharmaceuticals, Takeda Pharmaceuticals, Roche, Bluebird Bio, Cellectis, Sangamo Therapeutics and Fate Therapeutics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Cell therapy platform market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Cell therapy platform market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Cell therapy platform market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Cell therapy platform.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Cell therapy platform market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Cell therapy platform Market by Company
Novartis
Gilead Sciences
Regeneron Pharmaceuticals
Takeda Pharmaceuticals
Roche
Bluebird Bio
Cellectis
Sangamo Therapeutics
Fate Therapeutics
Cell therapy platform Segment by Type
Autologous Cell Therapy Platform
Allogeneic Cell Therapy Platform
Others
Cell therapy platform Segment by Application
General Hospital
Specialized Hospital
Others
Cell therapy platform Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cell therapy platform market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cell therapy platform and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cell therapy platform.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Cell therapy platform companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Autologous Cell Therapy Platform
- Allogeneic Cell Therapy Platform
- Others
Applications
- General Hospital
- Specialized Hospital
- Others
Companies covered
- Novartis
- Gilead Sciences
- Regeneron Pharmaceuticals
- Takeda Pharmaceuticals
- Roche
- Bluebird Bio
- Cellectis
- Sangamo Therapeutics
- Fate Therapeutics
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Cell therapy platform Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Cell therapy platform Market Size by Region (2021-2032)
- 1.4.1 Global Cell therapy platform Market Size by Region (2021-2026)
- 1.4.2 Global Cell therapy platform Market Size by Region (2027-2032)
- 1.5 Key Regions Cell therapy platform Market Size (2021-2032)
- 1.5.1 North America Cell therapy platform Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Cell therapy platform Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Cell therapy platform Market Size Growth Rate (2021-2032)
- 1.5.4 South America Cell therapy platform Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Cell therapy platform Market Size Growth Rate (2021-2032)
2 Cell therapy platform Market by Type
- 2.1 Type Introduction
- 2.1.1 Autologous Cell Therapy Platform
- 2.1.2 Allogeneic Cell Therapy Platform
- 2.1.3 Others
- 2.2 Global Cell therapy platform Market Size by Type
- 2.2.1 Global Cell therapy platform Market Size Overview by Type (2021-2032)
- 2.2.2 Global Cell therapy platform Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Cell therapy platform Market Size Forecasted by Type (2027-2032)
- 2.3 Global Cell therapy platform Market Size by Regions
- 2.3.1 North America Cell therapy platform Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Cell therapy platform Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Cell therapy platform Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Cell therapy platform Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Cell therapy platform Market Size Breakdown by Type (2021-2026)
3 Cell therapy platform Market by Application
- 3.1 Type Introduction
- 3.1.1 General Hospital
- 3.1.2 Specialized Hospital
- 3.1.3 Others
- 3.2 Global Cell therapy platform Market Size by Application
- 3.2.1 Global Cell therapy platform Market Size Overview by Application (2021-2032)
- 3.2.2 Global Cell therapy platform Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Cell therapy platform Market Size Forecasted by Application (2027-2032)
- 3.3 Global Cell therapy platform Market Size by Regions
- 3.3.1 North America Cell therapy platform Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Cell therapy platform Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Cell therapy platform Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Cell therapy platform Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Cell therapy platform Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Cell therapy platform Industry Trends
- 4.2 Cell therapy platform Industry Drivers
- 4.3 Cell therapy platform Industry Opportunities and Challenges
- 4.4 Cell therapy platform Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Cell therapy platform Revenue (2021-2026)
- 5.2 Global Cell therapy platform Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Cell therapy platform Key Company Headquarters & Area Served
- 5.4 Global Cell therapy platform Company, Product Type & Application
- 5.5 Global Cell therapy platform Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Cell therapy platform Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Cell therapy platform Players Market Share by Revenue in 2025
- 5.6.3 2025 Cell therapy platform Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Novartis
- 6.1.1 Novartis Company Information
- 6.1.2 Novartis Business Overview
- 6.1.3 Novartis Cell therapy platform Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Novartis Cell therapy platform Product Portfolio
- 6.1.5 Novartis Recent Developments
- 6.2 Gilead Sciences
- 6.2.1 Gilead Sciences Company Information
- 6.2.2 Gilead Sciences Business Overview
- 6.2.3 Gilead Sciences Cell therapy platform Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Gilead Sciences Cell therapy platform Product Portfolio
- 6.2.5 Gilead Sciences Recent Developments
- 6.3 Regeneron Pharmaceuticals
- 6.3.1 Regeneron Pharmaceuticals Company Information
- 6.3.2 Regeneron Pharmaceuticals Business Overview
- 6.3.3 Regeneron Pharmaceuticals Cell therapy platform Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Regeneron Pharmaceuticals Cell therapy platform Product Portfolio
- 6.3.5 Regeneron Pharmaceuticals Recent Developments
- 6.4 Takeda Pharmaceuticals
- 6.4.1 Takeda Pharmaceuticals Company Information
- 6.4.2 Takeda Pharmaceuticals Business Overview
- 6.4.3 Takeda Pharmaceuticals Cell therapy platform Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Takeda Pharmaceuticals Cell therapy platform Product Portfolio
- 6.4.5 Takeda Pharmaceuticals Recent Developments
- 6.5 Roche
- 6.5.1 Roche Company Information
- 6.5.2 Roche Business Overview
- 6.5.3 Roche Cell therapy platform Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Roche Cell therapy platform Product Portfolio
- 6.5.5 Roche Recent Developments
- 6.6 Bluebird Bio
- 6.6.1 Bluebird Bio Company Information
- 6.6.2 Bluebird Bio Business Overview
- 6.6.3 Bluebird Bio Cell therapy platform Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Bluebird Bio Cell therapy platform Product Portfolio
- 6.6.5 Bluebird Bio Recent Developments
- 6.7 Cellectis
- 6.7.1 Cellectis Company Information
- 6.7.2 Cellectis Business Overview
- 6.7.3 Cellectis Cell therapy platform Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Cellectis Cell therapy platform Product Portfolio
- 6.7.5 Cellectis Recent Developments
- 6.8 Sangamo Therapeutics
- 6.8.1 Sangamo Therapeutics Company Information
- 6.8.2 Sangamo Therapeutics Business Overview
- 6.8.3 Sangamo Therapeutics Cell therapy platform Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Sangamo Therapeutics Cell therapy platform Product Portfolio
- 6.8.5 Sangamo Therapeutics Recent Developments
- 6.9 Fate Therapeutics
- 6.9.1 Fate Therapeutics Company Information
- 6.9.2 Fate Therapeutics Business Overview
- 6.9.3 Fate Therapeutics Cell therapy platform Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Fate Therapeutics Cell therapy platform Product Portfolio
- 6.9.5 Fate Therapeutics Recent Developments
7 North America
- 7.1 North America Cell therapy platform Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Cell therapy platform Market Size by Country (2021-2026)
- 7.3 North America Cell therapy platform Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Cell therapy platform Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Cell therapy platform Market Size by Country (2021-2026)
- 8.3 Europe Cell therapy platform Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Cell therapy platform Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Cell therapy platform Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Cell therapy platform Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Cell therapy platform Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Cell therapy platform Market Size by Country (2021-2026)
- 10.3 South America Cell therapy platform Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Cell therapy platform Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Cell therapy platform Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Cell therapy platform Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst